News Releases
May 21 2002
Peregrine Pharmaceuticals Presents Data On Vasopermeation Enhancement Agent Technology At American Society of Clinical Oncology Annual Meeting
May 14 2002
Peregrine Pharmaceuticals Announces Publication of Data Demonstrating Development of Genetically Engineered TNT Antibody Fragments Expressed in Mammalian Cells
May 7 2002
Peregrine Pharmaceuticals Announces Abstracts of Interim Results From Tumor Necrosis Therapy Treatment of Lung and Hepatic Cancers
May 7 2002
Brain Tumor Action Week Pushes Disease Into Spotlight; Advances in Biotechnology Yield Promising Brain Tumor Treatments
May 7 2002
Correcting Symbol Interpretations; Greater Than Sted Less Than
May 6 2002
Peregrine Pharmaceuticals Sponsors Education Day During Brain Tumor Action Week; Week of May 5-11 Includes Advocacy Events and Candlelight Vigil
Apr 9 2002
Peregrine Pharmaceuticals Presents Advances in Vascular and Tumor Targeting Technologies at American Association for Cancer Research Annual Meeting
Mar 19 2002
Avid Bioservices Announces Manufacturing Supply Agreement With Inhibitex for the Production of Therapeutic Monoclonal Antibodies
Mar 18 2002
Peregrine Announces Quarterly Conference Call
Mar 13 2002
Avid Bioservices Announces Manufacturing Supply Agreement for the Production of a Therapeutic Monoclonal Antibody Intended for Phase III Clinical Trials